Literature DB >> 3686549

The pathologic and immunologic effects of inhaled acrolein in rats.

C L Leach1, N S Hatoum, H V Ratajczak, J M Gerhart.   

Abstract

Four groups of 40 male Sprague-Dawley rats each were exposed by inhalation to target concentrations of 0, 0.1, 1.0, and 3.0 ppm of acrolein 6 h/day, 5 days/week for 3 weeks. Subsequent changes in local pulmonary immunity were determined by examining the number of antibody plaque-forming cells in the lung-associated lymph nodes following intratracheal immunization with sheep red blood cells. Separate groups of rats were evaluated for blastogenic responsiveness to phytohemagglutinin-P and Salmonella typhimurium antigen using spleen- and lung-associated lymph node cells. In vivo resistance was evaluated utilizing acrolein-exposed rats subsequently challenged with intravenous Listeria monocytogenes. Local pulmonary antibody responsiveness was not affected by acrolein exposure. Lymphocyte blastogenesis and resistance to Listeria challenge were not altered. Body weights and spleen weights were decreased in the 3 ppm-exposed group only. Microscopic examination of the nasal turbinates revealed acrolein-induced exfoliation, erosion, and necrosis of the respiratory epithelium as well as squamous metaplasia, however, lung histology was not affected. Thus at environmental concentrations, acrolein toxicity appeared to be confined to local nasal pathologic changes with no alterations in lung histology or immune function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686549     DOI: 10.1016/0378-4274(87)90232-3

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  The tobacco smoke component, acrolein, suppresses innate macrophage responses by direct alkylation of c-Jun N-terminal kinase.

Authors:  Milena Hristova; Page C Spiess; David I Kasahara; Matthew J Randall; Bin Deng; Albert van der Vliet
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

2.  Subacute acrolein exposure to rat larynx in vivo.

Authors:  Xinxin Liu; Abigail C Durkes; William Schrock; Wei Zheng; M Preeti Sivasankar
Journal:  Laryngoscope       Date:  2018-12-24       Impact factor: 3.325

3.  Comparative Risks of Aldehyde Constituents in Cigarette Smoke Using Transient Computational Fluid Dynamics/Physiologically Based Pharmacokinetic Models of the Rat and Human Respiratory Tracts.

Authors:  Richard A Corley; Senthil Kabilan; Andrew P Kuprat; James P Carson; Richard E Jacob; Kevin R Minard; Justin G Teeguarden; Charles Timchalk; Sudhakar Pipavath; Robb Glenny; Daniel R Einstein
Journal:  Toxicol Sci       Date:  2015-04-08       Impact factor: 4.849

4.  Comparative computational modeling of airflows and vapor dosimetry in the respiratory tracts of rat, monkey, and human.

Authors:  Richard A Corley; Senthil Kabilan; Andrew P Kuprat; James P Carson; Kevin R Minard; Richard E Jacob; Charles Timchalk; Robb Glenny; Sudhakar Pipavath; Timothy Cox; Christopher D Wallis; Richard F Larson; Michelle V Fanucchi; Edward M Postlethwait; Daniel R Einstein
Journal:  Toxicol Sci       Date:  2012-05-12       Impact factor: 4.849

5.  Estimating risk from ambient concentrations of acrolein across the United States.

Authors:  Tracey J Woodruff; Ellen M Wells; Elizabeth W Holt; Deborah E Burgin; Daniel A Axelrad
Journal:  Environ Health Perspect       Date:  2006-12-11       Impact factor: 9.031

6.  Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology.

Authors:  O Moennikes; P M Vanscheeuwijck; B Friedrichs; E Anskeit; G J Patskan
Journal:  Inhal Toxicol       Date:  2008-05       Impact factor: 2.724

7.  Acrolein exposure suppresses antigen-induced pulmonary inflammation.

Authors:  Page C Spiess; David Kasahara; Aida Habibovic; Milena Hristova; Matthew J Randall; Matthew E Poynter; Albert van der Vliet
Journal:  Respir Res       Date:  2013-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.